Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responses

被引:43
作者
Banerjee, Arinjay [1 ,2 ,3 ,21 ]
El-Sayes, Nader [3 ,4 ]
Budylowski, Patrick [5 ]
Jacob, Rajesh Abraham [1 ,2 ,3 ]
Richard, Daniel [6 ]
Maan, Hassaan [7 ,8 ]
Aguiar, Jennifer A. [9 ]
Demian, Wael L. [1 ,2 ,3 ]
Baid, Kaushal [3 ,4 ]
D'Agostino, Michael R. [2 ,3 ,4 ]
Ang, Jann Catherine [2 ,3 ,4 ]
Murdza, Tetyana [3 ,4 ]
Tremblay, Benjamin J-M [9 ]
Afkhami, Sam [2 ,3 ,4 ]
Karimzadeh, Mehran [7 ]
Irving, Aaron T. [11 ,12 ]
Yip, Lily [13 ]
Ostrowski, Mario [14 ,15 ]
Hirota, Jeremy A. [2 ,16 ,17 ]
Kozak, Robert [13 ,18 ]
Capellini, Terence D. [6 ]
Miller, Matthew S. [2 ,3 ,4 ]
Wang, Bo [7 ,8 ,10 ,18 ]
Mubareka, Samira [13 ,18 ]
McGeer, Allison J. [19 ,20 ]
McArthur, Andrew G. [2 ,4 ]
Doxey, Andrew C. [2 ,9 ]
Mossman, Karen [1 ,2 ,3 ]
机构
[1] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada
[3] McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON L8S 4K1, Canada
[4] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada
[5] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada
[6] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA
[7] Vector Inst Artificial Intelligence, Toronto, ON M5G 1M1, Canada
[8] Univ Hlth Network, Peter Munk Cardiac Ctr, Toronto, ON M5G 2C4, Canada
[9] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada
[10] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 2E4, Canada
[11] Zhejiang Univ, Univ Edinburgh Inst, Haining 314400, Zhejiang, Peoples R China
[12] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Hangzhou 310027, Peoples R China
[13] Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada
[14] Univ Toronto, Dept Med, Toronto, ON M5S 3H2, Canada
[15] St Michaels Hosp, UnityHlth, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada
[16] McMaster Univ, Dept Med, Div Respirol, Hamilton, ON L8N 3Z5, Canada
[17] Univ British Columbia, Div Resp Med, Vancouver, BC V5Z 1M9, Canada
[18] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada
[19] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[20] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada
[21] Univ Saskatchewan, Dept Vet Microbiol, Vaccine & Infect Dis Org, Saskatoon, SK S7N 5E3, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
EAST RESPIRATORY SYNDROME; PAPAIN-LIKE PROTEASE; HUMAN CYTOMEGALOVIRUS; GROWTH-FACTORS; CORONAVIRUS; REPLICATION; PATHWAY; EXPRESSION; SARS; 4A;
D O I
10.1016/j.isci.2021.102477
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Type I interferons (IFNs) are our first line of defense against virus infection. Recent studies have suggested the ability of SARS-CoV-2 proteins to inhibit IFN responses. Emerging data also suggest that timing and extent of IFN production is associated withmanifestation of COVID-19 severity. In spite of progress in understanding how SARS-CoV-2 activates antiviral responses, mechanistic studies into wild-type SARS-CoV-2-mediated induction and inhibition of human type I IFN responses are scarce. Here we demonstrate that SARS-CoV-2 infection induces a type I IFN response in vitro and inmoderate cases of COVID-19. In vitro stimulation of type I IFN expression and signaling in human airway epithelial cells is associated with activation of canonical transcriptions factors, and SARS-CoV-2 is unable to inhibit exogenous induction of these responses. Furthermore, we show that physiological levels of IFNa detected in patients with moderate COVID-19 is sufficient to suppress SARS-CoV-2 replication in human airway cells.
引用
收藏
页数:23
相关论文
共 83 条
[21]   A SARS-CoV-2 protein interaction map reveals targets for drug repurposing [J].
Gordon, David E. ;
Jang, Gwendolyn M. ;
Bouhaddou, Mehdi ;
Xu, Jiewei ;
Obernier, Kirsten ;
White, Kris M. ;
O'Meara, Matthew J. ;
Rezelj, Veronica V. ;
Guo, Jeffrey Z. ;
Swaney, Danielle L. ;
Tummino, Tia A. ;
Huttenhain, Ruth ;
Kaake, Robyn M. ;
Richards, Alicia L. ;
Tutuncuoglu, Beril ;
Foussard, Helene ;
Batra, Jyoti ;
Haas, Kelsey ;
Modak, Maya ;
Kim, Minkyu ;
Haas, Paige ;
Polacco, Benjamin J. ;
Braberg, Hannes ;
Fabius, Jacqueline M. ;
Eckhardt, Manon ;
Soucheray, Margaret ;
Bennett, Melanie J. ;
Cakir, Merve ;
McGregor, Michael J. ;
Li, Qiongyu ;
Meyer, Bjoern ;
Roesch, Ferdinand ;
Vallet, Thomas ;
Mac Kain, Alice ;
Miorin, Lisa ;
Moreno, Elena ;
Naing, Zun Zar Chi ;
Zhou, Yuan ;
Peng, Shiming ;
Shi, Ying ;
Zhang, Ziyang ;
Shen, Wenqi ;
Kirby, Ilsa T. ;
Melnyk, James E. ;
Chorba, John S. ;
Lou, Kevin ;
Dai, Shizhong A. ;
Barrio-Hernandez, Inigo ;
Memon, Danish ;
Hernandez-Armenta, Claudia .
NATURE, 2020, 583 (7816) :459-+
[22]   PDGF Receptor and its Antagonists: Role in Treatment of PAH [J].
Grimminger, Friedrich ;
Schermuly, Ralph Theo .
MEMBRANE RECEPTORS, CHANNELS AND TRANSPORTERS IN PULMONARY CIRCULATION, 2010, 661 :435-446
[23]   Complex heatmaps reveal patterns and correlations in multidimensional genomic data [J].
Gu, Zuguang ;
Eils, Roland ;
Schlesner, Matthias .
BIOINFORMATICS, 2016, 32 (18) :2847-2849
[24]   Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients [J].
Hadjadj, Jerome ;
Yatim, Nader ;
Barnabei, Laura ;
Corneau, Aurelien ;
Boussier, Jeremy ;
Smith, Nikaia ;
Pere, Helene ;
Charbit, Bruno ;
Bondet, Vincent ;
Chenevier-Gobeaux, Camille ;
Breillat, Paul ;
Carlier, Nicolas ;
Gauzit, Remy ;
Morbieu, Caroline ;
Pene, Frederic ;
Marin, Nathalie ;
Roche, Nicolas ;
Szwebel, Tali-Anne ;
Merkling, Sarah H. ;
Treluyer, Jean-Marc ;
Veyer, David ;
Mouthon, Luc ;
Blanc, Catherine ;
Tharaux, Pierre-Louis ;
Rozenberg, Flore ;
Fischer, Alain ;
Duffy, Darragh ;
Rieux-Laucat, Frederic ;
Kerneis, Solen ;
Terrier, Benjamin .
SCIENCE, 2020, 369 (6504) :718-+
[25]   Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs [J].
Harding, Alfred T. ;
Heaton, Brook E. ;
Dumm, Rebekah E. ;
Heaton, Nicholas S. .
MBIO, 2017, 8 (03)
[26]   Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity [J].
Hoagland, Daisy A. ;
Moller, Rasmus ;
Uhl, Skyler A. ;
Oishi, Kohei ;
Frere, Justin ;
Golynker, Ilona ;
Horiuchi, Shu ;
Panis, Maryline ;
Blanco-Melo, Daniel ;
Sachs, David ;
Arkun, Knarik ;
Lim, Jean K. ;
tenOever, Benjamin R. .
IMMUNITY, 2021, 54 (03) :557-+
[27]   Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial [J].
Hung, Ivan Fan-Ngai ;
Lung, Kwok-Cheung ;
Tso, Eugene Yuk-Keung ;
Liu, Raymond ;
Chung, Tom Wai-Hin ;
Chu, Man-Yee ;
Ng, Yuk-Yung ;
Lo, Jenny ;
Chan, Jacky ;
Tam, Anthony Raymond ;
Shum, Hoi-Ping ;
Chan, Veronica ;
Wu, Alan Ka-Lun ;
Sin, Kit-Man ;
Leung, Wai-Shing ;
Law, Wai-Lam ;
Lung, David Christopher ;
Sin, Simon ;
Yeung, Pauline ;
Yip, Cyril Chik-Yan ;
Zhang, Ricky Ruiqi ;
Fung, Agnes Yim-Fong ;
Yan, Erica Yuen-Wing ;
Leung, Kit-Hang ;
Ip, Jonathan Daniel ;
Chu, Allen Wing-Ho ;
Chan, Wan-Mui ;
Ng, Anthony Chin-Ki ;
Lee, Rodney ;
Fung, Kitty ;
Yeung, Alwin ;
Wu, Tak-Chiu ;
Chan, Johnny Wai-Man ;
Yan, Wing-Wah ;
Chan, Wai-Ming ;
Chan, Jasper Fuk-Woo ;
Lie, Albert Kwok-Wai ;
Tsang, Owen Tak-Yin ;
Cheng, Vincent Chi-Chung ;
Que, Tak-Lun ;
Lau, Chak-Sing ;
Chan, Kwok-Hung ;
To, Kelvin Kai-Wang ;
Yuen, Kwok-Yung .
LANCET, 2020, 395 (10238) :1695-1704
[28]  
Hunt SE, 2018, DATABASE-OXFORD, DOI [10.1093/database/bay119, 10.1186/1471-2164-11-293]
[29]   SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70 [J].
Jiang, He-wei ;
Zhang, Hai-nan ;
Meng, Qing-feng ;
Xie, Jia ;
Li, Yang ;
Chen, Hong ;
Zheng, Yun-xiao ;
Wang, Xue-ning ;
Qi, Huan ;
Zhang, Jing ;
Wang, Pei-Hui ;
Han, Ze-Guang ;
Tao, Sheng-ce .
CELLULAR & MOLECULAR IMMUNOLOGY, 2020, 17 (09) :998-1000
[30]   Viruses and interferon: A fight for supremacy [J].
Katze, MG ;
He, YP ;
Gale, M .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (09) :675-687